Concepedia

Anshuman Panda

AP

13

Publications

1.4K

Citations

11

H-Index

2016

Active since

Affiliations

Rutgers, The State University of New Jersey(Current)

Rutgers Cancer Institute

Johnson University

Foundation Medicine (United States)

University of North Carolina at Chapel Hill

Anshuman Panda is an author at Rutgers, The State University of New Jersey specializing in medicine, cancer research, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2016–2021

13

Publications

13

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer

Janice M. Mehnert, Anshuman Panda, Kim M. Hirshfield et al. · Journal of Clinical Investigation · 2016 · 382 citations · Full text

, , +15

Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma

Christof C. Smith, Kathryn E. Beckermann, Dante S. Bortone et al. · Journal of Clinical Investigation · 2018 · 298 citations · Full text

Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer

Anshuman Panda, Janice M. Mehnert, Kim M. Hirshfield et al. · JNCI Journal of the National Cancer Institute · 2017 · 213 citations · Full text

Endogenous retrovirus expression is associated with response to immune checkpoint pathway in clear cell renal cell carcinoma

Anshuman Panda, Aguirre A. de Cubas, Mark N. Stein et al. · JCI Insight · 2018 · 171 citations · Full text

Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid Tumors

Anshuman Panda, Anil Malleshi Betigeri, Kalyanasundaram Subramanian et al. · JCO Precision Oncology · 2017 · 66 citations · Full text

Rows per page

1–5 of 13